U.S. Markets close in 3 hrs 53 mins

Delcath Systems, Inc. (DCTH)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1839+0.02 (+14.94%)
As of 12:07PM EDT. Market open.
People also watch
CLSNCYTRDXTRETRMANY
  • Stock gets hot and suddenly all the idiot trolls learn to use a keyboard.
    Morons.
  • Who is this imbecile Hugh Janus?
  • It is risky to sell your shares now - when results are expected this week or soon. Price could run to moon, if you sell, you regret.
  • Good resistance at .18. I bought back in this morning at .145. Hopefully good news this week.
  • opening prediction: .18 closing at .25 tomorrow.
  • Huge Janus is going to change his name to Blownout Janus by Wed morning.
  • .25 today?
  • I like heavily shorted stocks that have huge potential in terms of ACTUAL product line like DCTH. The more they short, the higher stock will go once PR hits the wire.

    All other garbage being pumped on this forum is pure scam - pump&dump. Do your own due diligence, and don't listen these scumbacks
  • 5 dollars
  • Here is something interesting:
    The specialty pharmaceutical and medical device company will release Phase 2 clinical data for a combination of Melphalan and its Hepatic Delivery System before the end of the month. [That means next week, folks!]
    http://stocknewsunion.com/delcath-systems-inc-nasdaqdcth-market-value-doubles/5815/

  • See you at 5 dollars!
  • Great volume (90m). Positive financials for 2Q should be out in the next weeks. Interim safety analysis due 2H 2017. Looks good, longs. Buy and hold.
  • Steve Clark---
    "The specialty pharmaceutical and medical device company will release Phase 2 clinical data for a combination of Melphalan and its Hepatic Delivery System before the end of the month. The treatment is being developed as a novel treatment for cancer of the liver and bile duct.
    Delcath Systems, Inc. (NASDAQ:DCTH) is also testing Melphalan Hydrochloride in a phase 3 clinical trial in patients with Ocular Melanoma. Developments in the oncology space should have a significant impact on the stock once the short sale circuit breaker is withdrawn."
  • Wait for the huge volume that will take this even higher after 8 am....go DCTH👍👍
  • When I sell, it goes up, and when I buy, it goes down. I'll just give you guys a heads up on what I'm about to do....
  • there product is SUCCESSFUL in Europe.
    big pharma buyout coming
  • I like the summary that insider trading has posted on the 26th...
    In other words, the company now asking shareholders to take a position based on the science as opposed to the potential for mismanagement and dilution. While it’s far from a sure thing, it’s a $26 million company with two very late stage assets in development in large, unmet healthcare indications. Take this valuation into consideration against the backdrop of some of its peers, and it looks plenty cheap at current prices.
  • not to sound greedy, but if it could hit $16.00-$20.00 today I wouldn't complain. haha
  • None of the executives have sold any shares
  • alex
    alex
    yesterday

    https://clinicaltrials.gov/ct2/show/study/NCT00096083

    Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer - Full Text View - ClinicalTrials.gov
    No Wonder the volume is so high lately , Something Positive will get it to around a dollar fast!

    Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer - Full Text View - ClinicalTrials.gov
    clinicaltrials.gov